OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
0227$0.2257

First Shanghai Investments Ltd

Investment Banking & Brokerage ServicesVerified

First Shanghai Investments Ltd operates with a market capitalization of HKD 473.19 million and a price-to-book ratio of 0.19, indicating a significant discount to its book value. The company's liquidity position is assessed as medium, with a current ratio of 1.43, suggesting it can cover its short-term liabilities but with limited buffer. The company's equity base of HKD 2.45 billion is supported by total assets of HKD 6.03 billion, but its net income of HKD -93.99 million and operating income of HKD -142.53 million indicate ongoing profitability challenges. The company's return on equity of -3.83% and return on assets of -1.56% are below the industry norms for investment banking and brokerage services, which typically require higher returns to justify capital deployment. The debt-to-equity ratio of 0.11 suggests a conservative capital structure, but the negative operating cash flow of HKD -293.49 million and free cash flow of HKD -58.96 million highlight liquidity constraints. The company's revenue is distributed across five segments: Financial Services, Property Development, Property Investment and Hotel, Medical and Healthcare, and Direct Investment. The Property Development segment is likely the largest contributor, but the company's exposure to property investment and hotel operations may be sensitive to real estate market cycles. The Medical and Healthcare segment is a newer addition, potentially offering diversification but also requiring significant capital investment. The company's revenue growth is constrained, with a net income decline and operating losses. The outlook for the current fiscal year is negative, with no clear indication of improvement in the next fiscal year. The company's capital expenditure of HKD -1.92 million is minimal, suggesting a focus on cost control rather than expansion. The company's risk profile includes medium liquidity risk and low dilution potential. The key risk flag is the negative net cash position after subtracting total debt, which could limit its ability to fund operations without external financing. The company has not issued new shares recently, and there is no indication of imminent dilution. Recent filings and transcripts do not indicate any major strategic shifts or operational changes. The company continues to operate in a challenging environment, with the financial services segment under pressure from low interest rates and regulatory scrutiny.

30-day price · 0227-0.02 (-7.8%)
Low$0.20High$0.24Close$0.20As of22 May, 00:00 UTC
Profile
CompanyFirst Shanghai Investments Ltd
Ticker0227.HK
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Banking & Brokerage Services
AI analysis

Business. First Shanghai Investments Ltd is an investment holding company engaged in financial services, property development and investment, hotel operations, and medical and healthcare services.

Classification. The company is classified under the industry "Investment Banking & Brokerage Services" within the "Banking & Investment Services" business sector, with a confidence level of 0.92.

First Shanghai Investments Ltd operates with a market capitalization of HKD 473.19 million and a price-to-book ratio of 0.19, indicating a significant discount to its book value. The company's liquidity position is assessed as medium, with a current ratio of 1.43, suggesting it can cover its short-term liabilities but with limited buffer. The company's equity base of HKD 2.45 billion is supported by total assets of HKD 6.03 billion, but its net income of HKD -93.99 million and operating income of HKD -142.53 million indicate ongoing profitability challenges. The company's return on equity of -3.83% and return on assets of -1.56% are below the industry norms for investment banking and brokerage services, which typically require higher returns to justify capital deployment. The debt-to-equity ratio of 0.11 suggests a conservative capital structure, but the negative operating cash flow of HKD -293.49 million and free cash flow of HKD -58.96 million highlight liquidity constraints. The company's revenue is distributed across five segments: Financial Services, Property Development, Property Investment and Hotel, Medical and Healthcare, and Direct Investment. The Property Development segment is likely the largest contributor, but the company's exposure to property investment and hotel operations may be sensitive to real estate market cycles. The Medical and Healthcare segment is a newer addition, potentially offering diversification but also requiring significant capital investment. The company's revenue growth is constrained, with a net income decline and operating losses. The outlook for the current fiscal year is negative, with no clear indication of improvement in the next fiscal year. The company's capital expenditure of HKD -1.92 million is minimal, suggesting a focus on cost control rather than expansion. The company's risk profile includes medium liquidity risk and low dilution potential. The key risk flag is the negative net cash position after subtracting total debt, which could limit its ability to fund operations without external financing. The company has not issued new shares recently, and there is no indication of imminent dilution. Recent filings and transcripts do not indicate any major strategic shifts or operational changes. The company continues to operate in a challenging environment, with the financial services segment under pressure from low interest rates and regulatory scrutiny.
Key takeaways
  • First Shanghai Investments Ltd is trading at a significant discount to book value, with a price-to-book ratio of 0.19.
  • The company is experiencing operating losses and negative cash flows, with a return on equity of -3.83%.
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.11, but liquidity is constrained.
  • The company's revenue is diversified across five segments, but the Property Development and Medical and Healthcare segments are the most significant.
  • The company's outlook is negative, with no clear path to profitability in the near term.
  • The company's risk profile includes medium liquidity risk and low dilution potential.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$407.6M
Gross profit$249.8M
Operating income-$142.5M
Net income-$94.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$293.5M
CapEx-$1.9M
Free cash flow-$59.0M
Total assets$6.03B
Total liabilities$3.57B
Total equity$2.45B
Cash & equivalents
Long-term debt$262.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.22
Market cap$473.2M
Enterprise value$736.1M
P/E
Reported non-GAAP P/E
EV/Revenue1.8
EV/Op income
EV/OCF
P/B0.2
P/Tangible book0.2
Tangible book$2.45B
Net cash-$262.9M
Current ratio1.4
Debt/Equity0.1
ROA-1.6%
ROE-3.8%
Cash conversion3.1%
CapEx/Revenue-0.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Banking & Investment Services · cohort 10 companies
Metric0227Activity
Op margin-35.0%26.6% medp25 13.9% · p75 29.0%bottom quartile
Net margin-23.1%18.8% medp25 13.7% · p75 22.7%bottom quartile
Gross margin61.3%67.6% medp25 41.5% · p75 93.2%below median
CapEx / revenue-0.5%1.2% medp25 0.4% · p75 1.9%bottom quartile
Debt / equity11.0%7.7% medp25 7.7% · p75 7.7%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 04:10 UTC#a71903a9
Market quoteclose HKD 0.22 · shares 2.19B diluted
no public URL
2026-05-10 04:10 UTC#6a2def03
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 04:12 UTCJob: 00f3f75c